NFKB1 and primary central nervous system lymphoma: Aberrant activation of nuclear factor kappa-B (NF-κB), an oncogenic hallmark of PCNSL, is driven by signaling pathways of B-cell receptor (BCR) and Toll-like receptor (TLR) [9].